Correlation Between Annexin Pharmaceuticals and Securitas

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Annexin Pharmaceuticals and Securitas at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Annexin Pharmaceuticals and Securitas into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Annexin Pharmaceuticals AB and Securitas AB, you can compare the effects of market volatilities on Annexin Pharmaceuticals and Securitas and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Annexin Pharmaceuticals with a short position of Securitas. Check out your portfolio center. Please also check ongoing floating volatility patterns of Annexin Pharmaceuticals and Securitas.

Diversification Opportunities for Annexin Pharmaceuticals and Securitas

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Annexin and Securitas is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Annexin Pharmaceuticals AB and Securitas AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Securitas AB and Annexin Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Annexin Pharmaceuticals AB are associated (or correlated) with Securitas. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Securitas AB has no effect on the direction of Annexin Pharmaceuticals i.e., Annexin Pharmaceuticals and Securitas go up and down completely randomly.

Pair Corralation between Annexin Pharmaceuticals and Securitas

Assuming the 90 days trading horizon Annexin Pharmaceuticals AB is expected to under-perform the Securitas. In addition to that, Annexin Pharmaceuticals is 1.87 times more volatile than Securitas AB. It trades about -0.02 of its total potential returns per unit of risk. Securitas AB is currently generating about 0.22 per unit of volatility. If you would invest  12,348  in Securitas AB on September 2, 2024 and sell it today you would earn a total of  1,447  from holding Securitas AB or generate 11.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Annexin Pharmaceuticals AB  vs.  Securitas AB

 Performance 
       Timeline  
Annexin Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Annexin Pharmaceuticals AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Annexin Pharmaceuticals is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Securitas AB 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Securitas AB are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental indicators, Securitas sustained solid returns over the last few months and may actually be approaching a breakup point.

Annexin Pharmaceuticals and Securitas Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Annexin Pharmaceuticals and Securitas

The main advantage of trading using opposite Annexin Pharmaceuticals and Securitas positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Annexin Pharmaceuticals position performs unexpectedly, Securitas can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Securitas will offset losses from the drop in Securitas' long position.
The idea behind Annexin Pharmaceuticals AB and Securitas AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences